Bayer Pharma AG v. Macleods Pharmaceuticals Ltd.

MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)

2025-06-09

1

Download

MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)

2025-06-09

2

View

DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

2025-06-09

1

View

[SEALED] COMPLAINT with Jury Demand against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. (Filing fee $ 405, receipt number ADEDC-4706261) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(mrr) (Entered: 06/09/2025)

2025-06-09

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/09/2025)

2025-06-09

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US, 10,828,310. (mrr) (Entered: 06/09/2025)

2025-06-09

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

2025-06-09

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

2025-06-09

1

View

Summons Issued as to Macleods Pharma USA, Inc. on 6/9/2025; Macleods Pharmaceuticals Ltd. on 6/9/2025. (Attachments: # 1 Summons Issued)(mrr) (Entered: 06/09/2025)

2025-06-09

1

View

ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 6/9/2025. (aas) (Entered: 06/09/2025)

2025-06-09

1

View

CORRECTING ENTRY: The docket text for D.I. 5 has been amended. The patent number has been corrected. The NEF for D.I. 5 has been regenerated. (nms)

2025-06-09

1

No Actions

Remark: Exit electronic copies to Judge, RGA (mrr)

2025-06-09

1

No Actions

- CORRECTING ENTRY

2025-06-09

1

No Actions

Remark: The MDL Panel has been notified of case 1:25-cv-00719-UNA which relates with 1:21-md-03017-RGA-LDH (mrr)

2025-06-09

1

No Actions

Remark

2025-06-09

1

No Actions

Case Assigned/Reassigned

2025-06-11

1

No Actions

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00719-UNA, 1:25-cv-00694-UNA (alb)

2025-06-11

1

No Actions

Redacted Document

2025-06-16

1

Download

Exs. A-B

2025-06-16

2

Download

Civil Cover Sheet

2025-06-16

2

Download

Summons Returned Executed

2025-07-02

1

View

Summons Returned Executed

2025-07-02

1

View

Extension of Time to File Answer

2025-07-02

1

View

SO ORDERED AND ~Util - Set/Reset Answer Deadline

2025-07-02

1

No Actions

Stipulation to EXTEND Time

2025-08-07

1

View

SO ORDERED AND ~Util - Set/Reset Answer Deadline

2025-08-08

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

2025-09-03

1

Download

NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek)

2025-09-03

1

Download

SO ORDERED

2025-09-03

1

No Actions

-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment

2025-09-03

1

No Actions

Answer to Complaint AND Counterclaim

2025-09-05

1

View

- CORRECTING ENTRY

2025-09-08

1

No Actions

Leave to File Document

2025-09-10

1

View

ORAL ORDER: The Unopposed Motion for Leave to File Answer and Counterclaims Under Seal (D.I. 18 in 25-cv-719-RGA; D.I. 360 in 21-md-3017-RGA-LDH) is GRANTED. Ordered by Judge Richard G. Andrews on 9/11/2025. Associated Cases: 1:25-cv-00719-RGA, 1:21-md-03017-RGA-LDH(nms)

2025-09-11

1

View

Oral Order

2025-09-11

1

No Actions

Answer to Complaint AND Counterclaim

2025-09-15

1

View

STIPULATION TO EXTEND TIME for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to answer, move, or otherwise respond to Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Answer and Counterclaims (C.A. No. 25-719-RGA, D.I. 20, MDL 21-3017-RGA, D.I. 362) to November 3, 2025 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

2025-09-19

1

Download

SO ORDERED AND ~Util - Set/Reset Answer Deadline

2025-09-19

1

No Actions

Deficiency re Redacted Documents

2025-09-22

1

No Actions

Redacted Document

2025-09-26

1

View

Deficiency re Redacted Documents

2025-09-26

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Corey Weinstein, Neal Seth and Wesley E. Weeks - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Stamoulis, Stamatios)

2025-09-30

1

Download

Redacted Document

2025-09-30

1

View

-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment

2025-09-30

1

No Actions

SO ORDERED

2025-09-30

1

No Actions

STIPULATION and [Proposed] Order Regarding Stay (as to C.A. No. 25-719-RGA) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

2025-10-27

1

Download

SO ORDERED Granting Stipulation and Order Regarding Stay (D.I. 26 in 25-cv-719-RGA; D.I. 184 in 21-cv-314-RGA-LDH; D.I. 381 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 10/28/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:25-cv-00719-RGA(nms)

2025-10-28

1

Download

STIPULATION TO EXTEND TIME for the parties to provide a joint status report to December 22, 2025 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

2025-12-08

1

Download

1 - Terminate Deadlines AND Order AND ~Util - Set Deadlines

2025-12-09

1

No Actions

SO ORDERED Granting Joint Stipulation to Extend Time to Provide Status Report to 12/22/2025 (D.I. 28 in 25-cv-719-RGA; D.I. 19 in 25-cv-349-RGA; D.I. 21 in 25-cv-753-RG; D.I. 28 in 24-cv-336-RGA; D.I. 15 in 25-cv-1043-RGA; D.I. 22 in 25-cv-754-RGA; D.I. 16 in 25-cv-694-RGA; D.I. 391 in 21-md-3017-RGA-LDH; D.I. 142 in 21-cv-1742-RGA; D.I. 24 in 25-cv-631-RGA; D.I. 186 in 21-cv-314-RGA-LDH; D.I. 27 in 23-cv-410-RGA. Ordered by Judge Richard G. Andrews on 12/9/2025. Associated Cases: 1:21-md-03017-RGA-LDH et al.(nms)

2025-12-09

1

No Actions

Stipulation of Dismissal

2025-12-11

1

View

Order AND ~Util - Terminate Civil Case

2025-12-11

1

View

Patent/Trademark Report to Commissioner of Patents

2025-12-11

1

View

Overview

Parties

Defendant

Macleods Pharma USA, Inc. Follow

Represented By

Macleods Pharmaceuticals Ltd. Follow

Represented By

Plaintiff

Janssen Pharmaceuticals, Inc. Follow

Represented By

Bayer AG Follow

Represented By

Bayer Pharma AG Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)

MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)

DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/09/2025)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US, 10,828,310. (mrr) (Entered: 06/09/2025)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)

Summons Issued as to Macleods Pharma USA, Inc. on 6/9/2025; Macleods Pharmaceuticals Ltd. on 6/9/2025. (Attachments: # 1 Summons Issued)(mrr) (Entered: 06/09/2025)

ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 6/9/2025. (aas) (Entered: 06/09/2025)

CORRECTING ENTRY: The docket text for D.I. 5 has been amended. The patent number has been corrected. The NEF for D.I. 5 has been regenerated. (nms)

Remark: Exit electronic copies to Judge, RGA (mrr)

- CORRECTING ENTRY

Remark: The MDL Panel has been notified of case 1:25-cv-00719-UNA which relates with 1:21-md-03017-RGA-LDH (mrr)

Remark

Case Assigned/Reassigned

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00719-UNA, 1:25-cv-00694-UNA (alb)

Redacted Document

Exs. A-B

Civil Cover Sheet

Summons Returned Executed

Summons Returned Executed

Extension of Time to File Answer

SO ORDERED AND ~Util - Set/Reset Answer Deadline

Stipulation to EXTEND Time

SO ORDERED AND ~Util - Set/Reset Answer Deadline

MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek)

SO ORDERED

-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment

Answer to Complaint AND Counterclaim

- CORRECTING ENTRY

Leave to File Document

ORAL ORDER: The Unopposed Motion for Leave to File Answer and Counterclaims Under Seal (D.I. 18 in 25-cv-719-RGA; D.I. 360 in 21-md-3017-RGA-LDH) is GRANTED. Ordered by Judge Richard G. Andrews on 9/11/2025. Associated Cases: 1:25-cv-00719-RGA, 1:21-md-03017-RGA-LDH(nms)

Oral Order

Answer to Complaint AND Counterclaim

SO ORDERED AND ~Util - Set/Reset Answer Deadline

Deficiency re Redacted Documents

Redacted Document

Deficiency re Redacted Documents

MOTION for Pro Hac Vice Appearance of Attorney Corey Weinstein, Neal Seth and Wesley E. Weeks - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Stamoulis, Stamatios)

Redacted Document

-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment

SO ORDERED

STIPULATION and [Proposed] Order Regarding Stay (as to C.A. No. 25-719-RGA) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

SO ORDERED Granting Stipulation and Order Regarding Stay (D.I. 26 in 25-cv-719-RGA; D.I. 184 in 21-cv-314-RGA-LDH; D.I. 381 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 10/28/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:25-cv-00719-RGA(nms)

STIPULATION TO EXTEND TIME for the parties to provide a joint status report to December 22, 2025 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)

1 - Terminate Deadlines AND Order AND ~Util - Set Deadlines

Stipulation of Dismissal

Order AND ~Util - Terminate Civil Case

Patent/Trademark Report to Commissioner of Patents

Track Case Updates

Macleods Pharma USA, Inc.

Macleods Pharmaceuticals Ltd.

Janssen Pharmaceuticals, Inc.

Bayer AG

Bayer Pharma AG